Status: current, Primitive. Date: 31-Mar 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3242491000168119 | Valsartan HCTZ 160/12.5 (Apotex) (trade product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3242501000168114 | Valsartan HCTZ 160/12.5 (Apotex) | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Valsartan HCTZ 160/12.5 (Apotex) | Is a | trade product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Valsartan HCTZ 160/12.5 (Apotex) (hydrochlorothiazide 12.5 mg + valsartan 160 mg) tablet (trade product unit of use) | Is a | True | Valsartan HCTZ 160/12.5 (Apotex) | Inferred relationship | Some | |
| Valsartan HCTZ 160/12.5 (Apotex) tablet, 28 | has TP | True | Valsartan HCTZ 160/12.5 (Apotex) | Inferred relationship | Some | |
| Valsartan HCTZ 160/12.5 (Apotex) tablet, 28, blister pack | has TP | True | Valsartan HCTZ 160/12.5 (Apotex) | Inferred relationship | Some |
Reference Sets
FHIR